ACHE and Alzheimer disease: Furthermore, is discussed the role of MPO as AD biomarker and revised some MPO inhibitors which could be a therapeutic strategy to mitigate oxidative damage in this disease and mention those that could have dual activity acting as MPO and acetylcholinesterase inhibitors.